Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ana Espinel-Ingroff

Showing results (41-50 of 50) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 50 results.
Medical Mycology|January 17, 2004
Status of medical mycology educationWilliam J Steinbach, Thomas G Mitchell, Wiley A Schell, et al.
Diagnostic Microbiology and Infectious Disease|April 7, 2012
Evaluation of disk diffusion method compared to broth microdilution for antifungal susceptibility testing of 3 echinocandins against Aspergillus sppAntonia Isabel Martos, Estrella Martín-Mazuelos, Ana Romero, et al.
Journal of Clinical Microbiology|November 10, 2006
Statistical analyses of correlation between fluconazole MICs for Candida spp. assessed by standard methods set forth by the European Committee on Antimicrobial Susceptibility Testing (E.Dis. 7.1) and CLSI (M27-A2)Juan Luis Rodriguez-Tudela, J Peter Donnelly, Michael A Pfaller, et al.
Journal of Clinical Microbiology|October 9, 2003
Successful outcome of disseminated Fusarium infection with skin localization treated with voriconazole and amphotericin B-lipid complex in a patient with acute leukemiaIsabelle Durand-Joly, Serge Alfandari, Zinnédine Benchikh, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 26, 2003
Voriconazole treatment for less-common, emerging, or refractory fungal infectionsJohn R Perfect, Kieren A Marr, Thomas J Walsh, et al.
Pathogens (Basel, Switzerland)|February 23, 2024
Antifungal Resistance in Cryptococcal InfectionsMarcia S C Melhem, Diniz Pereira Leite Júnior, Juliana P F Takahashi, et al.
Mycopathologia|March 5, 2016
Genotyping of Fusarium Isolates from Onychomycoses in Colombia: Detection of Two New Species Within the Fusarium solani Species Complex and In Vitro Antifungal Susceptibility TestingMarcela Guevara-Suarez, José Francisco Cano-Lira, María Caridad Cepero de García, et al.
Diagnostic Microbiology and Infectious Disease|May 7, 2011
Clinical breakpoints for voriconazole and Candida spp. revisited: review of microbiologic, molecular, pharmacodynamic, and clinical data as they pertain to the development of species-specific interpretive criteriaMichael A Pfaller, David Andes, Maiken C Arendrup, et al.
Microbial Cell (Graz, Austria)|July 12, 2018
Methodologies for <i>in vitro</i> and <i>in vivo</i> evaluation of efficacy of antifungal and antibiofilm agents and surface coatings against fungal biofilmsPatrick Van Dijck, Jelmer Sjollema, Bruno P Cammue, et al.
Msphere|September 7, 2017
Importance of Resolving Fungal Nomenclature: the Case of Multiple Pathogenic Species in the <i>Cryptococcus</i> GenusFerry Hagen, H Thorsten Lumbsch, Valentina Arsic Arsenijevic, et al.
Pageof 5

Showing results (41-50 of 50) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 50 results.
Medical Mycology|January 17, 2004
Status of medical mycology educationWilliam J Steinbach, Thomas G Mitchell, Wiley A Schell, et al.
Diagnostic Microbiology and Infectious Disease|April 7, 2012
Evaluation of disk diffusion method compared to broth microdilution for antifungal susceptibility testing of 3 echinocandins against Aspergillus sppAntonia Isabel Martos, Estrella Martín-Mazuelos, Ana Romero, et al.
Journal of Clinical Microbiology|November 10, 2006
Statistical analyses of correlation between fluconazole MICs for Candida spp. assessed by standard methods set forth by the European Committee on Antimicrobial Susceptibility Testing (E.Dis. 7.1) and CLSI (M27-A2)Juan Luis Rodriguez-Tudela, J Peter Donnelly, Michael A Pfaller, et al.
Journal of Clinical Microbiology|October 9, 2003
Successful outcome of disseminated Fusarium infection with skin localization treated with voriconazole and amphotericin B-lipid complex in a patient with acute leukemiaIsabelle Durand-Joly, Serge Alfandari, Zinnédine Benchikh, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 26, 2003
Voriconazole treatment for less-common, emerging, or refractory fungal infectionsJohn R Perfect, Kieren A Marr, Thomas J Walsh, et al.
Pathogens (Basel, Switzerland)|February 23, 2024
Antifungal Resistance in Cryptococcal InfectionsMarcia S C Melhem, Diniz Pereira Leite Júnior, Juliana P F Takahashi, et al.
Mycopathologia|March 5, 2016
Genotyping of Fusarium Isolates from Onychomycoses in Colombia: Detection of Two New Species Within the Fusarium solani Species Complex and In Vitro Antifungal Susceptibility TestingMarcela Guevara-Suarez, José Francisco Cano-Lira, María Caridad Cepero de García, et al.
Diagnostic Microbiology and Infectious Disease|May 7, 2011
Clinical breakpoints for voriconazole and Candida spp. revisited: review of microbiologic, molecular, pharmacodynamic, and clinical data as they pertain to the development of species-specific interpretive criteriaMichael A Pfaller, David Andes, Maiken C Arendrup, et al.
Microbial Cell (Graz, Austria)|July 12, 2018
Methodologies for <i>in vitro</i> and <i>in vivo</i> evaluation of efficacy of antifungal and antibiofilm agents and surface coatings against fungal biofilmsPatrick Van Dijck, Jelmer Sjollema, Bruno P Cammue, et al.
Msphere|September 7, 2017
Importance of Resolving Fungal Nomenclature: the Case of Multiple Pathogenic Species in the <i>Cryptococcus</i> GenusFerry Hagen, H Thorsten Lumbsch, Valentina Arsic Arsenijevic, et al.
Pageof 5